Early Detection and Intervention for Women At-risk of Psychosis

Sponsor
The University of Hong Kong (Other)
Overall Status
Recruiting
CT.gov ID
NCT03751865
Collaborator
(none)
160
1
2
57.5
2.8

Study Details

Study Description

Brief Summary

This study aims to examine the effectiveness of the cognitive behavioral therapy in preventing the conversion of psychosis in a sample of individuals at-risk for psychosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CBT
  • Behavioral: Psychoeducation
N/A

Detailed Description

Eligible subjects with informed consent provided will be randomly assigned to the cognitive behavioural therapy (CBT) group or psychoeducation group. Each group consists of 8 session spanning for 8 week.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Early Detection and Intervention for Women At-risk of Psychosis in Hong Kong: A Randomized Controlled Trial
Actual Study Start Date :
Nov 15, 2018
Anticipated Primary Completion Date :
Aug 30, 2021
Anticipated Study Completion Date :
Aug 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBT group

This intervention aims for distress reduction, symptom coping, and life quality enhancement. It is a gender-specific CBT tailor-made for the at-risk population. The intervention is delivered by a registered clinical psychologist.

Behavioral: CBT
A total of 8 CBT sessions will be provided to the participants, each session lasts for approximately 1.5 hour.

Active Comparator: Psychoeducation group

The content of the psycho-education program will be related to healthy living content and mental health knowledge, such as food hygiene, psychological well-being, knowledge about psychosis and common mental disorder and food nutrition. In addition, a weekly call to remind the subject about healthy living will also be provided to the subjects. The intervention is delivered by a registered social worker.

Behavioral: Psychoeducation
A total of 8 psychoeducation sessions will be provided to the participants, each session lasts for approximately 1.5 hour.

Outcome Measures

Primary Outcome Measures

  1. Functioning: Measured by Social and Occupational Functioning Assessment Scale (SOFAS) [Changes from baseline to immediate, 6- and 12-month post-intervention]

    Measured by Social and Occupational Functioning Assessment Scale (SOFAS). The SOFAS is an observer rating scale. Ratings should be based on subject's behavior during the last 1 month. The score ranges from 0-100. A higher score represents a better outcome.

  2. Functioning: Measured by Role Functioning Scale (RFS) [Changes from baseline to immediate, 6- and 12-month post-intervention]

    Measured by Role Functioning Scale (RFS). The RFS is comprised of four single rating scaled for evaluating the functioning of individuals in specified areas of everyday life. The four role functions assessed are:(1)Working: productivity, (2) Independent living and self care, (3) Immediate social network relationships, and (4) Extended social network relationship. The values on each of the four scales range from 1 (minimal level of role functioning), to 7 (hypothetically optimal level of role functioning). Each of the seven points on the scales is accompanied by a behaviorally defined description.

  3. Conversion of psychosis [12-month post-intervention]

    Proportion of subject that convert from at-risk state to psychosis

Secondary Outcome Measures

  1. Positive psychotic symptoms [Immediate, 6- and 12-month post-intervention]

    Measurement of positive symptoms using the Chinese version of the Psychotic Symptom Rating Scales (C-PSYRATS). It comprises of the auditory hallucinations (AHS) and delusions subscales (DS). The AHS has 11 questions and the DS consists of 6 questions, each question has the responses ranging from 0-4. The higher score represents more severe positive psychotic symptoms.

  2. Beliefs about the auditory hallucination [Immediate, 6- and 12-month post-intervention]

    Measured by the Beliefs About Voices Questionnaire (BAVQ-R). The BAVQ-R has 35 questions, the 4 responses range from disagree, unsure, slightly agree to strongly agree. The higher score represents more convicted belief about the voices.

  3. Depressive symptoms [Immediate, 6- and 12-month post-intervention]

    Measured by the Calgary Depression Scale for Schizophrenia (CDSS). The scale consists of 9 questions, each has the response ranging from 0 to 3. The higher score presents more severe depressive symptoms.

  4. Social anxiety :Measured by Liebowitz Social Anxiety Scale (LSAS) [Immediate, 6- and 12-month post-intervention]

    Measured by Liebowitz Social Anxiety Scale (LSAS). The LSAS consists of 24 questions, the rater has to rate from 0-3 in Fear or Anxiety domain or Avoidance domain for each of the 24 questions. The higher score represents more severe social anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • women of age 18-64

  • at-risk mental state as defined by the Comprehensive Assessment of At-Risk Mental States (CAARMS)

  • with an informed consent

  • able to understand Cantonese and read/write Chinese

Exclusion Criteria:
  • those mental conditions that requires other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)

  • those medical conditions that severely limits participation, comprehension, or adherence to the treatment (e.g., epilepsy, dementia, terminal medical illness);

  • those who are receiving structured psychotherapy or counselling

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Hong Kong Hong Kong Hong Kong 0000

Sponsors and Collaborators

  • The University of Hong Kong

Investigators

  • Principal Investigator: Eric Yu Hai Chen, MD, The University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Professor Eric Y.H. Chen, Chi-li Pao Foundation Professor of Psychiatry; Chair Professor in Psychiatry; Head, Department of Psychiatry, The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT03751865
Other Study ID Numbers:
  • JCWowCBT
  • UW 18-231
First Posted:
Nov 23, 2018
Last Update Posted:
Apr 20, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 20, 2021